For patients with er or pr positive, stage ic-iii breast cancer, clinician documented or prescribed that the patient is receiving tamoxifen or aromatase inhibitor
This is the 2008 version of HCPCS G8381 - please refer to the 2016 HCPCS code set for the latest version.
Status changed on Sunday, July 01, 2007 to: Add procedure or modifier code
